Stock-based compensation increased 71.9%
Stock-based compensation changed +71.9% from the comparable as-filed period.
$4.3M→$7.4M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →BYND financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
SBC / revenue moved 501 bp higher
SBC / revenue changed +501 basis points from the comparable as-filed period.
5.74%→10.75%2 prior comparisons
Gross profit decreased 31.6%
Gross profit changed -31.6% from the comparable as-filed period.
$8.6M→$5.9M2 prior comparisons
Operating income increased 11.8%
Operating income changed +11.8% from the comparable as-filed period.
-$34.9M→-$30.8M2 prior comparisons
Revenue decreased 8.2%
Revenue changed -8.2% from the comparable as-filed period.
$75.0M→$68.8M2 prior comparisons
Working capital / assets moved 284 bp higher
Working capital / assets changed +284 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
29.92%→32.76%4 prior comparisons
Debt / revenue moved 111705 bp lower
Debt / revenue changed -111705 basis points from the comparable as-filed period.
1587.47%→470.41%2 prior comparisons
Working capital decreased 11.4%
Working capital changed -11.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$206.9M→$183.4M4 prior comparisons
Free-cash-flow margin moved 1839 bp higher
Free-cash-flow margin changed +1839 basis points from the comparable as-filed period.
-46.89%→-28.50%2 prior comparisons
Operating cash-flow margin moved 1797 bp higher
Operating cash-flow margin changed +1797 basis points from the comparable as-filed period.
-44.30%→-26.34%2 prior comparisons
Receivables / revenue moved 1244 bp lower
Receivables / revenue changed -1244 basis points from the comparable as-filed period.
49.81%→37.37%2 prior comparisons
Capital expenditure decreased 23.2%
Capital expenditure changed -23.2% from the comparable as-filed period.
$1.9M→$1.5M3 prior comparisons
Capex / revenue moved 42 bp lower
Capex / revenue changed -42 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
2.59%→2.16%2 prior comparisons
R&D / revenue moved 166 bp lower
R&D / revenue changed -166 basis points from the comparable as-filed period.
7.75%→6.09%2 prior comparisons
Selling, general & administrative decreased 13.8%
Selling, general & administrative changed -13.8% from the comparable as-filed period.
$37.7M→$32.5M2 prior comparisons
Current long-term debt changed across a zero base
Current long-term debt changed from 0 to 29459000 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
$0→$29.5M0 prior comparisons
Cost of revenue decreased 5.1%
Cost of revenue changed -5.1% from the comparable as-filed period.
$66.4M→$63.0M2 prior comparisons
Current assets decreased 0.5%
Current assets changed -0.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$297.1M→$295.6M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.